$Elevai Labs, Inc.(ELAB)$ Elev

$Elevai Labs, Inc.(ELAB)$ Elevai Labs (ELAB) announce it has signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune Bio (INMB). The licensing agreement grants Elevai a license to use INmune Bio's proprietary "EMx" technology, developed by INmune Bio, Inc., CMO, Mark Lowdell, PhD, that enables Elevai to manufacture current Good Manufacturing Practice grade, human umbilical cord-derived mesenchymal stromal cells (hucMSCs) at a lower cost to Elevai than purchasing hucMSCs outright. Manufactured hucMSCs can be incorporated into certain licensed topical cosmetic products sold in the medical aesthetics skincare market.... They are seeking more expansion, and you know what it means...

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":264094208757760,"tweetId":"264094208757760","gmtCreate":1705497478392,"gmtModify":1705497483640,"author":{"id":9000000000000715,"idStr":"9000000000000715","authorId":9000000000000715,"authorIdStr":"9000000000000715","name":"AmandaViolet","avatar":"https://static.tigerbbs.com/3bd13bb5008c812d906b648f773f9ffe","vip":8,"userType":8,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":23,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p> <a data-mention-id=\"ELAB\" class=\"teditor-mention\" data-mention-name=\"Elevai Labs, Inc.\" href=\"https://ttm.financial/S/ELAB\">$Elevai Labs, Inc.(ELAB)$</a> Elevai Labs (ELAB) announce it has signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune Bio (INMB). The licensing agreement grants Elevai a license to use INmune Bio's proprietary \"EMx\" technology, developed by INmune Bio, Inc., CMO, Mark Lowdell, PhD, that enables Elevai to manufacture current Good Manufacturing Practice grade, human umbilical cord-derived mesenchymal stromal cells (hucMSCs) at a lower cost to Elevai than purchasing hucMSCs outright. Manufactured hucMSCs can be incorporated into certain licensed topical cosmetic products sold in the medical aesthetics skincare market.... They are seeking more expansion, and you know what it means...</p></body></html>","htmlText":"<html><head></head><body><p> <a data-mention-id=\"ELAB\" class=\"teditor-mention\" data-mention-name=\"Elevai Labs, Inc.\" href=\"https://ttm.financial/S/ELAB\">$Elevai Labs, Inc.(ELAB)$</a> Elevai Labs (ELAB) announce it has signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune Bio (INMB). The licensing agreement grants Elevai a license to use INmune Bio's proprietary \"EMx\" technology, developed by INmune Bio, Inc., CMO, Mark Lowdell, PhD, that enables Elevai to manufacture current Good Manufacturing Practice grade, human umbilical cord-derived mesenchymal stromal cells (hucMSCs) at a lower cost to Elevai than purchasing hucMSCs outright. Manufactured hucMSCs can be incorporated into certain licensed topical cosmetic products sold in the medical aesthetics skincare market.... They are seeking more expansion, and you know what it means...</p></body></html>","text":"$Elevai Labs, Inc.(ELAB)$ Elevai Labs (ELAB) announce it has signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune Bio (INMB). The licensing agreement grants Elevai a license to use INmune Bio's proprietary \"EMx\" technology, developed by INmune Bio, Inc., CMO, Mark Lowdell, PhD, that enables Elevai to manufacture current Good Manufacturing Practice grade, human umbilical cord-derived mesenchymal stromal cells (hucMSCs) at a lower cost to Elevai than purchasing hucMSCs outright. Manufactured hucMSCs can be incorporated into certain licensed topical cosmetic products sold in the medical aesthetics skincare market.... They are seeking more expansion, and you know what it means...","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/264094208757760","repostId":0,"isVote":1,"tweetType":1,"viewCount":835,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["ELAB"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":633,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/264094208757760"}